G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 26.45 SEK -3.47%
Market Cap: 1.7B SEK
Have any thoughts about
Genovis AB?
Write Note

Genovis AB
Total Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genovis AB
Total Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Assets CAGR 3Y CAGR 5Y CAGR 10Y
G
Genovis AB
STO:GENO
Total Assets
kr303.4m
CAGR 3-Years
42%
CAGR 5-Years
48%
CAGR 10-Years
25%
AddLife AB
STO:ALIF B
Total Assets
kr12.7B
CAGR 3-Years
45%
CAGR 5-Years
37%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Total Assets
kr6.1B
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Total Assets
kr4.9B
CAGR 3-Years
48%
CAGR 5-Years
29%
CAGR 10-Years
23%
MedCap AB (publ)
STO:MCAP
Total Assets
kr1.9B
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
13%
M
Magle Chemoswed Holding AB
STO:MAGLE
Total Assets
kr273m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Genovis AB
Glance View

Market Cap
1.7B SEK
Industry
Life Sciences Tools & Services

Genovis AB engages in the research and development of enzyme products. The company is headquartered in Lund, Skane. The company went IPO on 2005-11-11. The firm offers products within two product portfolios, namely protein portfolio and nano portfolio. The protein portfolio develops products within the areas of cancer, inflammatory and autoimmune diseases. The portfolio comprises FabRICATOR, a genetically modified enzyme the cleaves antibodies in two parts, and IgGZERO, a protein that specifically cleaves the sugar molecules that occur naturally on antibodies. The products within the nano portfolio are primarily directed at the preclinical market. The firm markets and sells its products through dealers and distributors in the European, North American and Asian continents. As of December 31, 2011, it operated a wholly owned subsidiary, Eijdo Research AB.

GENO Intrinsic Value
25.55 SEK
Overvaluation 3%
Intrinsic Value
Price
G

See Also

What is Genovis AB's Total Assets?
Total Assets
303.4m SEK

Based on the financial report for Jun 30, 2024, Genovis AB's Total Assets amounts to 303.4m SEK.

What is Genovis AB's Total Assets growth rate?
Total Assets CAGR 10Y
25%

Over the last year, the Total Assets growth was 44%. The average annual Total Assets growth rates for Genovis AB have been 42% over the past three years , 48% over the past five years , and 25% over the past ten years .

Back to Top